Lexet

Quick links to important sections

Lexet

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lexet

What is Lexet? A Foundational Overview

Lexet is a prescription medicine containing the active ingredient Pravastatin Sodium, which is classified pharmacologically as an HMG-CoA Reductase Inhibitor. It is an oral medication, provided as a synthetic, single-ingredient compound in the dosage form of a tablet. The core function of Lexet is to systematically address the elevated levels of lipids, or fats, in the bloodstream, specifically targeting cholesterol production. Lexet is generally available as a prescription-only (Rx) drug in major global markets.


Quick Facts

Property Description
Active ingredient Pravastatin Sodium
Form Tablet (Oral solid dosage)
Pharmacological class HMG-CoA Reductase Inhibitor (Statin)
General Purpose Lipid-modifying agent
Origin Semi-synthetic

What Type of Medicine is Lexet? Classification and Purpose

Lexet belongs to the major pharmacological class of drugs known as Statins, which are broadly designated as Antihyperlipidemic agents. This classification signifies that the drug is designed to help modulate and reduce high concentrations of fats, particularly cholesterol, in the body. The primary utility of Lexet is to manage and significantly reduce levels of Low-Density Lipoprotein Cholesterol (LDL-C), often referred to as "bad cholesterol," to support a healthier lipid balance. The active ingredient, Pravastatin, is clinically recognized for reducing elevated total cholesterol and LDL-C levels.

A differentiating factor for Pravastatin is its hydrophilic (water-soluble) nature, which is distinct from the lipophilic (fat-soluble) properties of certain other Statins. This characteristic often leads to a more targeted action within the liver tissue.


How Does Lexet Generally Work? (High-Level Principle)

The action of Lexet is centered on competitive enzyme inhibition, a direct mechanism that controls the internal synthesis of cholesterol. The active substance, Pravastatin, targets and physically blocks the specific enzyme, HMG-CoA Reductase, which is responsible for a critical step in the liver's natural manufacturing process of cholesterol. By inhibiting this key enzyme, the medication effectively controls cholesterol production at its source. Statins like Pravastatin achieve lipid lowering by blocking cholesterol synthesis.

What side effects are possible with Lexet?

Possible Side Effects and Safety Information

The safety profile for Lexet (Pravastatin Sodium), an HMG-CoA Reductase Inhibitor, is based on classifications from official regulatory documents and is grouped by frequency and affected body systems.

Frequency and System-Organ Classes

The most frequently reported adverse reactions are classified as Common (may affect up to 1 in 10 people) and primarily involve the Musculoskeletal and Gastrointestinal systems. These commonly documented effects include myalgia (muscle pain), arthralgia (joint pain), headache, dizziness, fatigue, and digestive disturbances such as nausea, vomiting, and diarrhea. Uncommon reactions may involve the skin, presenting as rash or pruritus, and the nervous system, noted as insomnia.

Serious Adverse Reactions and Safety Constraints

Official prescribing information highlights the potential for serious adverse reactions, categorized as Rare or Very Rare. The most clinically significant concern is rhabdomyolysis, a severe muscle syndrome, and hepatic failure. The risk of myopathy, which can precede rhabdomyolysis, is explicitly noted to be associated with both treatment initiation and long-term exposure, and it may be increased when Pravastatin is co-administered with certain other medications. Regulatory documentation establishes a key safety constraint: the medication is generally restricted or contraindicated in patients with active liver disease or unexplained, persistent elevations of liver transaminases. Specific safety information for pediatric patients (aged ge 8 years) is available for certain indications, and use is contraindicated during pregnancy and lactation.

Overdose and Emergency Response

Overdose and when to seek help

Suspected overdosage with the active ingredient in Lexet (Pravastatin Sodium) requires immediate medical attention. If a victim has collapsed, experienced a seizure, or has trouble breathing, emergency services or the Poison Control Center must be contacted at once.

The regulatory profile documents that overdose may present with common manifestations such as nausea, vomiting, diarrhea, headache, and dizziness.

Classification Domain Official Regulatory Summary
Severe Complications Risks include Rhabdomyolysis (severe muscle breakdown), Acute Renal Failure, and Hepatotoxicity (liver damage).
Management Principle Treatment is symptomatic and supportive, as no specific antidote is known for overdosage.

When Urgent Medical Help is Required

Urgent medical assessment is mandated upon the appearance of symptoms indicative of severe toxicity, including unexplained muscle pain or weakness, dark-colored urine, or signs of liver impairment (e.g., yellowing of the skin or eyes). These symptoms require the immediate cessation of the medicine. Monitoring of Creatine Phosphokinase (CPK) levels and Liver Function Tests (LFTs) is required to assess for tissue damage. Population-specific considerations note that individuals with advanced age or renal impairment are at an increased risk for severe skeletal muscle effects in this context.

The official overdose information focuses on the potential for severe muscle and hepatic toxicity, necessitating the mandated procedure of supportive care and critical laboratory monitoring to manage the physiological systems affected by high exposure.

Therapeutic Uses of Lexet

What Lexet Treats: Main Uses and Benefits

Lexet is authorized for the relief of symptoms associated with specific allergic conditions. It is indicated for the management of perennial allergic rhinitis, which refers to symptoms that persist year-round. This includes assistance with common issues such as a runny nose, sneezing, and itchy or watery eyes.

The medication may also be used to address the discomfort caused by seasonal allergic rhinitis, frequently triggered by airborne allergens like pollen. Furthermore, Lexet is utilized in the therapeutic domain of chronic idiopathic urticaria (hives). In this context, it contributes to the relief of associated symptoms, including the appearance of rash, swelling, and itching.

Lexet is designed to address the body's response to allergens by modulating certain chemical messengers. For complete regulatory and prescribing information, please refer to the official product monograph or professional labeling.

Patients should consult with a healthcare professional to determine if this treatment is appropriate for their specific needs and to discuss all potential risks and benefits. Treatment aims to support symptom control and improve overall quality of life.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lexet? (Official Regulatory Information)

Eligibility for Lexet (halobetasol propionate) foam is strictly governed by regulatory guidelines pertaining to age, duration of use, quantity, and application site.

Populations and Use Restrictions

Criteria Eligibility Status
Age Approved for patients 12 years of age and older. Safety and effectiveness are not established in children younger than 12.
Application Site Prohibited on the face, groin, axillae (underarms), and in the eye, mouth, or vagina.
Duration & Quantity Use is limited to a maximum of 2 consecutive weeks. The total dosage should not exceed 50 grams per week.

Special Populations

Use is conditional for pregnant or breastfeeding individuals, requiring a clinical assessment as safety is not known. If used while breastfeeding, application near the nipple/areola area is prohibited.

Patients with conditions that increase the risk of systemic absorption, such as liver impairment or a higher susceptibility to Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, may require monitoring or restricted use. The drug is classified as Category C for pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents structure the official interaction profile for Lexet (Pravastatin Sodium) around two primary risks: an increased risk of muscular toxicity and modification of the drug's plasma exposure.


Interaction Classifications and Rules

Classification Type Detail / Regulatory Basis
Severity Classification Contraindicated/Not Recommended: Concomitant use with Gemfibrozil and Systemic Fusidic Acid is formally restricted due to the heightened risk of myopathy and rhabdomyolysis.
Exposure-Modifying Agents Substances like Cyclosporine and the macrolide antibiotics Clarithromycin and Erythromycin increase Pravastatin's systemic exposure. This pharmacokinetic effect often requires regulatory-specified maximum daily dosages.
Timing-Based Rules Bile Acid Sequestrants (e.g., Cholestyramine) decrease Pravastatin absorption. Pravastatin must be administered at least 1 hour before or at least 4 hours after the sequestrant.

Official Interaction Statements

  • The use of other Fibrates (besides Gemfibrozil), Niacin (in doses 1 g/day), and Colchicine all present a pharmacodynamic interaction that increases the shared risk of adverse skeletal muscle effects.
  • Official labeling notes that predisposing factors such as Advanced Age or a history of Renal Impairment may heighten the risk of muscular toxicity when Pravastatin is used in combination with interacting medicines.
  • Consumption of substantial quantities of alcohol is noted in regulatory warnings as potentially increasing the risk of liver problems.

Mechanism of Action

How Lexet Works

Lexet's mechanism is defined by a dual action on cholesterol homeostasis, influencing both the endogenous production and the enhanced hepatic clearance of Low-Density Lipoprotein Cholesterol (LDL-C).


Blocking the Liver's Cholesterol Production

The drug's primary action is the competitive inhibition of the enzyme HMG-CoA Reductase, which is the critical rate-limiting enzyme in the liver's Mevalonate pathway for cholesterol synthesis. This molecular blockade inhibits the body’s internal manufacturing of new cholesterol, initiating a downstream cellular response.


Enhancing Systemic Clearance via Receptor Upregulation

The drop in intracellular cholesterol triggers a compensatory response: the liver cells significantly upregulate (increase the number of) LDL Receptors on their surface. This significantly enhances the cell's capacity to internalize LDL-C from the bloodstream. The resulting physiological effect is a substantial reduction in circulating LDL-C and the overall modulation of the systemic lipid profile.

Dosage and Administration Information

How to Use Lexet (Pravastatin Sodium)

Lexet is administered exclusively by the oral route as a solid tablet, with administration intended for long-term therapy to control chronic lipid levels. The initiation of treatment requires patients to be placed on a standard cholesterol-lowering diet, which must be maintained throughout the course of medication use.

Dosing and Schedule

Administration occurs once daily as a single dose. While Lexet may be taken with or without food and at any time of day, administration typically occurs in the evening.

Usage Group Typical Starting Dose Maximum Daily Dose
Adults 40 mg once daily 80 mg once daily
Pediatric (8–13 yrs) 20 mg once daily

Administration Contexts

Dosage adjustments are determined by a healthcare professional based on periodic lipid profile determinations, with the first re-evaluation of response typically performed after approximately 4 weeks of therapy.

Specific dosing modifications apply to certain patient populations and co-administered drugs:

  • Severe Renal Impairment: The recommended maximum daily dose is 40 mg.
  • Bile Acid Sequestrants: Lexet must be taken at least one hour before or four hours after administration of these agents to ensure adequate absorption. The maximum dose is also limited when co-administered with certain drugs, such as Cyclosporine (to 20 mg daily).

Recent Clinical Evidence

Lexet: Recent Clinical Evidence

Evaluation of Therapeutic Use in Rheumatoid Arthritis (RA)

Research has explored Lexet’s potential to influence the production of certain inflammation-causing chemicals. It is a therapeutic agent that has been studied in the management of chronic autoimmune conditions.

Studies have investigated whether Lexet is associated with changes in pain and swelling symptoms for individuals with moderate-to-severe rheumatoid arthritis (RA). Clinical trials have evaluated the drug's effect on the time to symptom onset and whether it is associated with a lasting change in measures of disease activity.

Clinical data has been gathered to evaluate the percentage of participants who reported notable changes in symptoms within the first six weeks of treatment. Studies have assessed whether the drug shows therapeutic effect and evaluated the frequency of adverse events in adults over extended treatment periods.

Combination Therapy and Long-Term Outcomes

Researchers have examined the use of the drug in combination with other therapeutic agents to evaluate potential differences in outcome measures. Research explored the drug's potential association with changes in markers of joint damage progression.

The collective evidence has been reviewed to assess the drug's outcome measures against those reported for older treatment options.

Safety Profile and Use in Specific Populations

Studies examined the occurrence of cardiovascular adverse events in participants with pre-existing heart conditions.

Investigators have examined whether a lower dose in children is associated with similar changes in symptom control measures compared to the standard adult dose. The drug has been studied as a therapeutic option for individuals with conditions that have shown limited response to other treatments.

Key Studies & References

  1. ACR Guideline for the Treatment of Rheumatoid Arthritis (2021 Update)

Frequently Asked Questions (FAQ)

Common questions about Lexet (FAQ)

Q: What is the active ingredient in Lexet and what type of medicine is it?

Lexet's active ingredient is Escitalopram. According to official product information, it belongs to a group of medicines called Selective Serotonin Reuptake Inhibitors (SSRIs). SSRIs work by increasing the level of a natural substance in the brain called serotonin, which is involved in mood regulation.


Q: What medical conditions is Lexet used to treat?

Regulatory documents state that Lexet is approved for the treatment of major depressive episodes and various anxiety disorders. These conditions include panic disorder, social anxiety disorder, generalised anxiety disorder, and obsessive-compulsive disorder (OCD). Lexet is used to help manage the symptoms associated with these diagnoses.


Q: How long does it typically take for Lexet to start working?

Official information indicates that it can take some time before a patient notices the full effect of Lexet. While some patients may start to feel relief after a couple of weeks, research suggests the full antidepressant effect may take 2-4 weeks to be noticed. Patients are advised to continue following the prescribed treatment plan, as any change in medication should only occur after consulting a healthcare provider.


Q: Can Lexet be used in children and adolescents?

According to the official product information, Lexet is not recommended for use in children and adolescents under 18 years of age. This recommendation is based on concerns regarding the risk of increased suicide-related behaviors and hostility in this age group. A healthcare professional can discuss the risks and benefits of use in young patients.


Q: Is it safe to drink alcohol while taking Lexet?

Regulatory documents advise avoiding the combination of Lexet and alcohol. Although Escitalopram is not expected to significantly interact with alcohol, combining them is generally discouraged. Alcohol may worsen the symptoms of the underlying condition or impact performance during treatment.

How should Lexet be stored and disposed of?

How to Store and Dispose of Lexet?

Storing Lexet (Pravastatin Sodium) correctly maintains its stability, and proper disposal ensures environmental safety, according to regulatory guidelines.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20^circC to 25^circC (68^circF to 77^circF).
Protection Keep the container tightly closed and protect the tablets from moisture and excessive heat or freezing.
Security Store the medication out of the sight and reach of children and pets.

Disposal Instructions

Do not flush unused or expired Lexet down a toilet or pour it into a drain. Disposal must follow official methods, such as utilizing a drug take-back program or mail-back envelope. The regulations prohibit releasing the substance into the environment, including sewer systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lexet found in:

A-Z Index: